Tag: U.K.
-
Contact Lens Devised to Measure Glaucoma Eye Pressure
Engineers in the U.K. developed a soft contact lens that in a clinical study shows it can reliably track changes in pressure inside the eye, a key factor in glaucoma.
-
Field Tests of Genetically Modified Moths to Begin
Outdoor tests of a genetically engineered diamondback moth, a difficult agricultural pest, altered to stop reproducing and collapse the species, are about to get underway.
-
Trial Underway Testing Alzheimer’s-Schizophrenia Drug
A new clinical trial began in the U.K. in a test of an experimental drug to treat schizophrenia associated with Alzheimer’s disease.
-
Trial Shows Smartphone App Finds More Heart Disease
Results from a clinical trial show an electrocardiogram app on a smartphone detects more cases of irregular heart beats than routine office visits.
-
AstraZeneca, Biotech Partner on Messenger RNA Therapies
Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments.
-
3-D Printing Process Developed for Living Tissue
Researchers in the U.K. devised 3-D printing techniques for human and animal cells to produce functioning tissue with multiple types of cells.
-
Peptide Immunotherapy Shown Safe for Type 1 Diabetes
In an early clinical trial, researchers in the U.K. show treatments with peptides, fragments of proteins, are safe and can slow the progression of type 1 diabetes.
-
Faster Process Devised for Targeted Antibodies
Researchers in the U.S. and U.K. designed techniques for quickly generating highly targeted antibodies in the lab, which can speed production of new vaccines and therapies.
-
Clinical Trial Begins for Liver Dialysis Device
A clinical trial is underway in Europe testing a device that works like dialysis to clear toxins from the blood associated with liver failure, where a transplant is often the only option.
-
Grant Funding Automated Genome Editing System
A consortium of companies and university in the U.K. and U.S. are developing an automated desktop genome editing system using the emerging Crispr technique.